Entyvio
Entyvio (vedolizumab) is used in adults for the treatment of moderate to severe Ulcerative Colitis or Crohn’s Disease.
Archive for Ulcerative Colitis (UC)
Remicade
Remicade (infliximab) is indicated for the treatment of Crohn’s Disease, Ulcerative Colitis…
Renflexis
Renflexis (infliximab-abda) is a biosimilar of Remicade. Renflexis is indicated for the treatment of Crohn’s Disease
Stelara IV
Stelara (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of Crohn’s Disease and UC as well as other diseases
Stelara SQ
STELARA® as an injection under the skin (subcutaneous injection) every 8 weeks. STELARA® is a prescription biologic medicine used for the treatment of Crohn’s Disease and Ulcerative Colitis (UC) as well as other diseases including moderate to severe plaque psoriasis (Ps) and phototherapy or systemic therapy patients with active psoriatic arthritis (PsA).
Avsola
Avsola (infliximab-axxq) is a biosimilar of Remicade. Avsola is indicated for the treatment of Crohn’s Disease…
Omvoh
OMVOH is indicated for the treatment of moderately to severely active ulcerative colitis in adults.
Tremfya
TREMFYA is a prescription medicine used to treat adults with moderate to severe Ulcerative Colitis.